Mar 02, 2020 / 04:20PM GMT
Marc Alan Frahm - Cowen and Company, LLC, Research Division - VP
All right. Thanks for joining here at the Cowen Health Care Conference. Before anything else -- at Cowen Health Care Conference. Really excited to start off the company presentations today with -- fireside chat here with Incyte. We have Steven Stein, the CMO; and Christiana Stamoulis, the CFO, with us.
Questions and Answers:
Marc Alan Frahm - Cowen and Company, LLC, Research Division - VPMaybe just to start off, Christiana, if you want to talk -- a year or so ago, some investors were worried that the launch of INREBIC could kind of increase the rate of Jakafi discontinuations and really impact kind of trends on Jakafi. So maybe if you can -- now that we're about 7 months into the launch, say, discuss how INREBIC has actually changed the market, good, bad or your insight for Jakafi trends? And any impact on pricing flexibility kind of moving forward?
Christiana Stamoulis - Incyte Corporation - Executive VP & CFO
Okay, great. Is this working?
Trustpilot
